Business Description
GlycoNex Inc
ISIN : TW0004168000
Total Employee Number:
35Description
GlycoNex Inc is a Taiwan-based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The other services provided by the firm include functional evaluation, antibody research, and antibody engineering. It has two reportable segments: antibody new drug, which derives maximum revenue, and exclusive investment. Geographically, the group derives maximum revenue from Taiwan and the rest from Japan.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.46 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | -2.48 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.55 | |||||
Beneish M-Score | -1.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.8 | |||||
3-Year EPS without NRI Growth Rate | 0.6 | |||||
3-Year FCF Growth Rate | 3.5 | |||||
3-Year Book Growth Rate | -13.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.76 | |||||
9-Day RSI | 36.54 | |||||
14-Day RSI | 40.1 | |||||
3-1 Month Momentum % | 6.98 | |||||
6-1 Month Momentum % | -13.95 | |||||
12-1 Month Momentum % | 2.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8 | |||||
Quick Ratio | 8 | |||||
Cash Ratio | 7.42 | |||||
Days Sales Outstanding | 8.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | -13.97 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 62.1 | |||||
Operating Margin % | -659.81 | |||||
Net Margin % | -621.29 | |||||
EBITDA Margin % | -506.25 | |||||
FCF Margin % | -456.57 | |||||
OCF Margin % | -439.2 | |||||
ROE % | -23.34 | |||||
ROA % | -16.81 | |||||
ROIC % | -26.08 | |||||
3-Year ROIIC % | 5.94 | |||||
ROC (Joel Greenblatt) % | -28.25 | |||||
ROCE % | -18.89 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 67.96 | |||||
PB Ratio | 2.71 | |||||
Price-to-Tangible-Book | 2.72 | |||||
EV-to-EBIT | -10.76 | |||||
EV-to-EBITDA | -12.74 | |||||
EV-to-Revenue | 64.5 | |||||
EV-to-FCF | -14 | |||||
Price-to-GF-Value | 0.31 | |||||
Price-to-Median-PS-Value | 0.04 | |||||
| Price-to-Net-Current-Asset-Value | 15.06 | |||||
| Price-to-Net-Cash | 21.9 | |||||
Earnings Yield (Greenblatt) % | -9.29 | |||||
FCF Yield % | -6.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlycoNex Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 37.861 | ||
| EPS (TTM) (NT$) | -2.158 | ||
| Beta | 0.5276 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 35.29 | ||
| 14-Day RSI | 40.1 | ||
| 14-Day ATR (NT$) | 0.879348 | ||
| 20-Day SMA (NT$) | 24.94 | ||
| 12-1 Month Momentum % | 2.68 | ||
| 52-Week Range (NT$) | 20.55 - 30 | ||
| Shares Outstanding (Mil) | 112.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlycoNex Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlycoNex Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.1:1 Stock Split | 2014-08-12 | 81.98 (-1.09%) | ||
| 1.1135:1 Stock Split | 2013-08-05 | 77.84 (-10.92%) | ||
| 1.018:1 Stock Split | 2012-06-25 | 75.90 (+0.00%) |
Show
Entries
GlycoNex Inc Frequently Asked Questions
What is GlycoNex Inc(ROCO:4168)'s stock price today?
The current price of ROCO:4168 is NT$23.65. The 52 week high of ROCO:4168 is NT$30.00 and 52 week low is NT$20.55.
When is next earnings date of GlycoNex Inc(ROCO:4168)?
The next earnings date of GlycoNex Inc(ROCO:4168) is .
Does GlycoNex Inc(ROCO:4168) pay dividends? If so, how much?
GlycoNex Inc(ROCO:4168) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on GlycoNex Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers